Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids
about
Targeting sigma receptors: novel medication development for drug abuse and addictionThe Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of CivilizationRecreational use, analysis and toxicity of tryptaminesNPS: Medical Consequences Associated with Their IntakeAyahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine.An ontogenic study of the behavioral effects of chronic intermittent exposure to ayahuasca in mice.Chronic intermittent exposure to ayahuasca during aging does not affect memory in miceComparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in ratsAbuse liability profile of three substituted tryptamines.Psychedelic drug use in healthy individuals: A review of benefits, costs, and implications for drug policyThe hallucinogenic world of tryptamines: an updated review.Clinical applications of hallucinogens: A review.Analytical techniques for the determination of tryptamines and β-carbolines in plant matrices and in psychoactive beverages consumed during religious ceremonies and neo-shamanic urban practices.Safety and side effects of ayahuasca in humans--an overview focusing on developmental toxicology.Classical and novel psychoactive substances: rethinking drug misuse from an evolutionary psychiatric perspective.A critical evaluation of reports associating ayahuasca with life-threatening adverse reactions.Behavioral Changes Over Time Following Ayahuasca Exposure in ZebrafishPotential Use of Ayahuasca in Grief Therapy.Therapeutic Applications of Classic Hallucinogens.The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging.Switch to mania after ayahuasca consumption in a man with bipolar disorder: a case report.Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample.A single administration of the hallucinogen, 4-acetoxy-dimethyltryptamine, prevents the shift to a drug-dependent state and the expression of withdrawal aversions in rodents.Experiences of encounters with ayahuasca--"the vine of the soul".Ritualistic Use of Ayahuasca versus Street Use of Similar Substances Seized by the Police: A Key Factor Involved in the Potential for Intoxications and Overdose?Therapeutic effects of ritual ayahuasca use in the treatment of substance dependence--qualitative results.Forbidden therapies: Santo Daime, ayahuasca, and the prohibition of entheogens in Western society.Assessment of Alcohol and Tobacco Use Disorders Among Religious Users of Ayahuasca.Acute Intoxication following Dimethyltryptamine Ingestion.: An ancient sacrament for treatment of contemporary psychiatric illness?LC-MS/MS Quantitative Determination ofTetrapterys mucronataAlkaloids, a Plant Occasionally used in Ayahuasca Preparation
P2860
Q24622567-72838D87-BF0B-4788-919D-0A133CCF75F9Q26765995-C8C1D9F9-D704-4CCD-876D-CF377A84DF9AQ27027080-9674DCBB-F9CD-47AC-A224-8004D66C3A0EQ28276182-2C6F8AD1-88AA-4590-BA36-9FD7A020A875Q33693380-A25CB2AB-1B2E-404F-B89B-CDBC71AC679FQ33740814-43036ACC-99C2-4692-B544-C726FC006168Q33777061-EC954B2F-B40A-4C88-8AC2-524769145C31Q33777066-8D159CEC-226A-44E4-9DD8-B1BA2D39E8E4Q33833054-8BDCD803-11B4-479C-9670-4731D031461FQ34176654-CA7076EC-E0BA-4C5D-8CEB-EA03BD134E7FQ34178760-18A1BF58-30DC-46D5-B87D-233CAEC21B22Q34471834-6895874C-14FB-4316-A5F4-3247770D9066Q34535259-4A86B667-3883-4272-A944-984675D129C7Q38009283-32174177-2C6D-49D5-A0AA-412322B05F93Q38105566-81C05678-5956-434D-A276-76C17904368AQ38123779-C62D47D1-CE9F-41E2-B75D-3A2C1290F03FQ38126030-05DDF645-201F-4547-9139-C2A66CC4D7DEQ38626654-2C5057AA-4AA2-4FB9-AEF9-B848F17932E5Q38757125-394D7AD1-E077-4F52-A657-324D0BD0BCFEQ38781678-6447498C-7B09-47E9-9CC5-F7F77B38EB38Q38861685-139B4853-C8CF-4C8D-80C3-8E6FAE10B0FAQ42088743-5B73FD44-D51D-4980-AB45-8A63AF01ACFDQ45383954-1B0669F6-F408-45D9-8D5D-54A9AD4D8817Q47351706-DF1A2E4A-EB30-4B07-A122-1D23ABA3F46CQ47401762-12EF99E7-8002-4831-A1F8-77F8428F7ABBQ47414743-8A20305F-A7F4-4A70-8E28-9BD72096A5BCQ47643640-658B62BF-1F2E-445F-AC8A-6E9071427881Q47675823-F12A3204-6F7A-40EE-B38F-CBD5B4BCFCEBQ55234376-40570C3E-FD38-44B1-AA6F-6CF375BE3FE3Q55283483-867DF37A-CBD3-4B34-A7E0-BE3C55AD22BAQ56852531-A9EB659A-7704-4076-9CD6-8A4A855C7FAEQ57017524-CA5AA9AF-E63A-445E-99C7-FBD3F413A585
P2860
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids
@ast
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids
@en
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids
@nl
type
label
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids
@ast
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids
@en
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids
@nl
prefLabel
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids
@ast
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids
@en
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids
@nl
P2860
P1433
P1476
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids
@en
P2093
Robert S. Gable
P2860
P356
10.1111/J.1360-0443.2006.01652.X
P407
P577
2007-01-01T00:00:00Z